Vaxcyte Inc
PCVXHealthcare|Biotechnology|USA
$58.20
-1.62 (-2.71%)
Tangible Book
$20.76
Earnings Power
$7.32
About
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
Stock Price
+60.6%(1Y)
Pipeline Summary
9 total trials3
Phase 1
5
Phase 2
3
Phase 3
0
Phase 4
Completed: 4Active: 4Recruiting: 1
Active Trials (5)
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age
NCT07365826Pneumococcal Vaccines
Phase 3Active
Enrollment: 1,390 participants
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49
NCT07284654Pneumococcal Vaccines
Phase 3Active
Enrollment: 4,049 participants
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-A1 in Healthy Young Adults
NCT07616934Group A Streptococcal Infection
Phase 1Recruiting
Enrollment: 80 participants
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants
NCT06720038Pneumococcal Vaccines
Phase 2Active
Enrollment: 900 participants
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination
NCT07425392Pneumococcal Vaccines
Phase 3Active
Enrollment: 752 participants
BioScore
6.2/10
Watchlist
Ownership
Recent Insider Trades
GUGGENHIME ANDREWSELL
2026-07-0610,000 shares @ $57.28
Wassil JimSELL
2026-07-012,250 shares @ $56.33
PICKERING GRANTSELL
2026-06-2624,237 shares @ $55.22
PICKERING GRANTSELL
2026-06-1824,461 shares @ $52.5
GUGGENHIME ANDREWSELL
2026-06-1810,000 shares @ $53
Recent News
2026-06-15 21:00:07
Data last updated: Jul 12, 2026, 07:38 PM